Study shows frailty and social vulnerability increase with age and are linked to higher mortality and functional decline, emphasizing the need for dual-targeted interventions in older adults.
Roche’s Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS